https://www.nytimes.com/interactive/2020/us/covid-19-vaccine...
https://www.nytimes.com/interactive/2020/us/covid-19-vaccine...
Wtf? How have they lost 3.5m doses? They can't all be "delivered to site but not used yet" can they?
Thanks BTW, I'm shocked by this news.
The companies running the vaccinations for those facilities have visited ~10% of the facilities so far. I suppose they have a large allocation despite that rate because the populations in the facilities tend to be high risk.
The easier to handle vaccines can't come soon enough at this point. Hopefully the production issue with the J&J vaccine doesn't impact later batches (hopefully having them producing tens of millions of doses by April and May).
(giving a dose to a vulnerable person in a few days is pretty clearly more beneficial than giving it to a low risk person today; if the administration wasn't performing well vs the rest of the state or the interval were longer it'd be a more difficult consideration)
I suppose we'd need a lot more data to confirm whether this understandably part of a ramp up or if its evidence of incompetent management...
(It's not clear if is really 40 million, but slow administration is a broad issue. And now there's a question of how much is going to be available each week; if the supply is X/week, it's going to be hard to convince people to build the capability to administer 2x/week)
That's not entirely clear to me, if the "low risk" person is in a position to be a superspreader. Vaccinating a supermarket checkout worker now, vs an elderly person (who gets delivery food and never meets anyone) in a few days, could easily save many more lives.
Low paid staff stealing them and selling them on the private market. Single dose was going for over $5000 a few weeks ago.